OTCMKTS:PTIX - Protagenic Therapeutics Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$1.76 -0.44 (-20.00 %)
(As of 05/22/2018 03:27 PM ET)
Previous Close$2.20
Today's Range$1.76 - $1.76
52-Week Range$1.75 - $2.20
Volume1,300 shs
Average Volume3 shs
Market Capitalization$20.52 million
P/E RatioN/A
Dividend YieldN/A
Beta-11.62

About Protagenic Therapeutics (OTCMKTS:PTIX)

Protagenic Therapeutics, Inc., formerly Atrinsic, Inc., is a development-stage company. The Company is a biotechnology company that specializes in the discovery and development of therapeutics to treat central nervous system (CNS) disorders. The Company provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-base, brain active therapeutics. The Company has developed a portfolio of neuropeptides that are in various stages of development and preclinical evaluation for the treatment of various mood disorders. These neuropeptides are called PT00114, PT00121, PT00211, PT00311 and PT00411. As of September 30, 2016, the Company has not generated any revenue.

Receive PTIX News and Ratings via Email

Sign-up to receive the latest news and ratings for PTIX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Business services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:PTIX
CUSIPN/A
Phone212-994-8200

Debt

Debt-to-Equity RatioN/A
Current Ratio2.92
Quick Ratio2.92

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book Value$0.12 per share
Price / Book14.67

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-2,250,000.00
Net MarginsN/A
Return on Equity-154.13%
Return on Assets-111.60%

Miscellaneous

Employees3
Outstanding Shares10,260,000

Protagenic Therapeutics (OTCMKTS:PTIX) Frequently Asked Questions

What is Protagenic Therapeutics' stock symbol?

Protagenic Therapeutics trades on the OTCMKTS under the ticker symbol "PTIX."

How were Protagenic Therapeutics' earnings last quarter?

Protagenic Therapeutics (OTCMKTS:PTIX) issued its quarterly earnings data on Tuesday, May, 15th. The biotechnology company reported ($0.06) earnings per share for the quarter. View Protagenic Therapeutics' Earnings History.

When is Protagenic Therapeutics' next earnings date?

Protagenic Therapeutics is scheduled to release their next quarterly earnings announcement on Tuesday, August, 14th 2018. View Earnings Estimates for Protagenic Therapeutics.

Who are some of Protagenic Therapeutics' key competitors?

Who are Protagenic Therapeutics' key executives?

Protagenic Therapeutics' management team includes the folowing people:
  • Garo H. Armen Ph.D., Chairman of the Board (Age 64)
  • Alexander K. J. Arrow M.D., Acting Chief Financial Officer (Age 47)
  • Joshua N. Silverman, Director (Age 46)
  • Robert Burton Stein, Director (Age 66)
  • Khalil Z. Barrage, Independent Director (Age 51)
  • Brian Corvese, Independent Director

Has Protagenic Therapeutics been receiving favorable news coverage?

News stories about PTIX stock have trended somewhat negative this week, Accern reports. The research firm identifies negative and positive media coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Protagenic Therapeutics earned a daily sentiment score of 0.00 on Accern's scale. They also gave media coverage about the biotechnology company an impact score of 47.98 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near future.

How do I buy shares of Protagenic Therapeutics?

Shares of PTIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Protagenic Therapeutics' stock price today?

One share of PTIX stock can currently be purchased for approximately $1.76.

How big of a company is Protagenic Therapeutics?

Protagenic Therapeutics has a market capitalization of $20.52 million. Protagenic Therapeutics employs 3 workers across the globe.

How can I contact Protagenic Therapeutics?

Protagenic Therapeutics' mailing address is 149 FIFTH AVENUE SUITE 500, NEW YORK NY, 10010. The biotechnology company can be reached via phone at 212-994-8200 or via email at [email protected]


MarketBeat Community Rating for Protagenic Therapeutics (PTIX)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  31 (Vote Outperform)
Underperform Votes:  34 (Vote Underperform)
Total Votes:  65
MarketBeat's community ratings are surveys of what our community members think about Protagenic Therapeutics and other stocks. Vote "Outperform" if you believe PTIX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PTIX will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Protagenic Therapeutics (OTCMKTS:PTIX) Analyst Ratings History

DateBrokerageActionRatingPrice TargetDetails
(Data available from 5/22/2016 forward)

Earnings

Protagenic Therapeutics (OTCMKTS:PTIX) Earnings History and Estimates Chart

Earnings by Quarter for Protagenic Therapeutics (OTCMKTS:PTIX)

Protagenic Therapeutics (OTCMKTS PTIX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/14/2018        
5/15/2018Q1 2018($0.06)ViewN/AView Earnings Details
11/13/2017Q3 2017($0.04)ViewN/AView Earnings Details
8/8/2017Q2 2017($0.04)ViewN/AView Earnings Details
5/15/2017Q1 2017($0.06)ViewN/AView Earnings Details
11/17/2016Q3 2016($0.06)ViewN/AView Earnings Details
8/15/2016Q2 2016($14.93)ViewN/AView Earnings Details
11/7/2013Q313$0.07$4.70 million$7.30 millionViewN/AView Earnings Details
8/8/2013Q2 2013$0.06$5.00 million$7.10 millionViewN/AView Earnings Details
11/8/2012Q312($0.12)$9.00 million$4.70 millionViewN/AView Earnings Details
11/14/2011Q3 2011($7,544.84)ViewN/AView Earnings Details
8/15/2011Q2 2011($15,058.75)ViewN/AView Earnings Details
5/16/2011Q1 2011($8,627.09)ViewN/AView Earnings Details
3/31/2011Q4 2010($8,348.80)ViewN/AView Earnings Details
11/15/2010Q3 2010($10,760.67)ViewN/AView Earnings Details
8/16/2010Q2 2010($13,605.44)ViewN/AView Earnings Details
5/11/2010Q1 2010($9,894.87)ViewN/AView Earnings Details
3/30/2010Q4 2009($19,789.73)ViewN/AView Earnings Details
11/11/2009Q3 2009($7,173.78)ViewN/AView Earnings Details
8/14/2009Q2 2009($5,936.92)ViewN/AView Earnings Details
5/12/2009Q1 2009($3,525.05)ViewN/AView Earnings Details
3/26/2009Q4 2008($5,071.12)ViewN/AView Earnings Details
8/14/2008Q2 2008$4,329.00ViewN/AView Earnings Details
5/15/2008Q1 2008($865.80)ViewN/AView Earnings Details
3/27/2008Q4 2007($4,823.75)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Protagenic Therapeutics (OTCMKTS:PTIX) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Protagenic Therapeutics (OTCMKTS PTIX) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 42.00%
Insider Trading History for Protagenic Therapeutics (OTCMKTS:PTIX)

Protagenic Therapeutics (OTCMKTS PTIX) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/28/2013Quaker Capital Management CorpMajor ShareholderSell100,000$1.25$125,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Protagenic Therapeutics (OTCMKTS PTIX) News Headlines

Source:
DateHeadline
Protagenic Therapeutics (PTIX) Releases Quarterly  Earnings ResultsProtagenic Therapeutics (PTIX) Releases Quarterly Earnings Results
www.americanbankingnews.com - May 16 at 2:21 PM

SEC Filings

Protagenic Therapeutics (OTCMKTS:PTIX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Protagenic Therapeutics (OTCMKTS:PTIX) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Protagenic Therapeutics (OTCMKTS PTIX) Stock Chart for Tuesday, May, 22, 2018

Loading chart…

This page was last updated on 5/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.